Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related PFE
Evercore ISI Technical Analysis: The 'Single Best Idea'
Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices
Expanded label for Pfizer's Prevenar 13 pneumonia vaccine cleared in Europe (Seeking Alpha)
Related LNKD
CORRECTION: Ignore LinkedIn Headline, Company Did Not Announce A $5M Series A Funding Round
The Top 10 Analysts On Wall Street
The Improbable Road to Nasdaq 5,000 (Fox Business)

Analysts at Citigroup initiated coverage on shares of Pfizer (NYSE: PFE) with a “buy” rating. Pfizer's shares closed at $24.85 yesterday. Pfizer's trailing-twelve-month operating margin is 31.27%.

Wedbush initiated coverage on shares of LinkedIn (NYSE: LNKD) with a “neutral” rating. LinkedIn's stock closed at $107.11 yesterday. LinkedIn's trailing-twelve-month ROE is 2.76%.

Wells Fargo initiated coverage on shares of Hess (NYSE: HES) with a “market perform” rating. Hess' shares closed at $50.50 yesterday. Hess had $528.00 million in total cash for the recent quarter.

Analysts at Mizuho initiated coverage on shares of Salix Pharmaceuticals (NASDAQ: SLXP) with a “buy” rating. Salix's shares closed at $41.26 yesterday. Salix's PEG ratio is 0.62.

Latest Ratings for PFE

DateFirmActionFromTo
Feb 2015JefferiesMaintainsBuy
Feb 2015JP MorganMaintainsOverweight
Feb 2015CitigroupMaintainsBuy

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (HES + LNKD)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→